 (Gut 1995; 36: 346-350) 
Cell proliferation was increased in Hpylori associated gastritis patients compared with normal controls and patients with H pylon negative chronic gastritis (p=0.0001; Tukey's Studentised range). There was no difference in antral epithelial cell proliferation between duodenal ulcer and non-ulcer subjects infected with H pylon (p=0.62; Student's t test). Antral mucosal cell proliferation fell four weeks after completing triple therapy, irrespective of whether or not H pylon had been eradicated (p=0.0001). At retesting six to 18 months later (mean= 12 months), however, those in whom Hpylori had not been successfully eradicated showed increased mucosal proliferation compared with both H pylon negative subjects at a similar follow up interval and all cases (whether H pylon positive or negative) four weeks after completion of triple therapy (p=0.024). These findings suggest that Hpylori infection causes increased gastric cell proliferation and in this way may play a part in gastric carcinogenesis. (Gut 1995; 36: 346-350) Keywords: Helicobacter pylori, type B gastritis, gastric cancer, cell proliferation. the S phase of the cell cycle.8 9 This method correlates well with the in vivo method10 11 and was used in preference to the simpler technique of proliferating cell nuclear antigen (PCNA) immunostaining. PCNA is overexpressed in gastric mucosal biopsy specimens12 13 and is a poor marker of cell proliferation at this site.9
We have shown that gastric mucosal cell proliferation, as measured by the labelling index, is increased in H pylon associated chronic gastritis but not in chronic gastritis where the organism is absent. This suggests that chronic inflammation alone is not associated with increased gastric epithelial cell turnover and that H pylori infection is required. Cytokines, free oxygen radicals, and other factors released by the inflammatory response after infection with H pylori 14 15 may interact with cells in the proliferative compartment to increase cell proliferation. The density of inflammatory cell infiltration in the region of the isthmus of the gastric glands is consistent with this explanation. Alternatively, the increased cell proliferation may be a direct compensatory response to accelerated cell loss, and be related to an increase in the activity of growth factors. Growth factor receptors are highly expressed in the prolifera- We have shown similar increases in antral mucosal cell proliferation in ulcer and nonulcer patients. Non-ulcer associated gastritis usually affects both the antrum and corpus of the stomach (pangastritis) and is associated with a higher risk of gastric carcinoma than the predominantly antral, duodenal ulcer-associated gastritis. The difference in topographical distribution of non-ulcer associated gastritis is thought to account for the difference in cancer risk.1920 The histological and physiological changes that occur in pangastritis, namely atrophy and intestinal metaplasia in both antrum and corpus, lead to hypochlorhydria and proliferation of bacteria capable of nitrate reduction. This could result in production of nitrosocompounds which may be responsible for mutagenic events. The normal or increased acid levels in duodenal ulcer subjects would prevent this situation arising. The mucosal damage caused by H pylori may allow nitrosocompounds and other mutagenic agents such as bile and free radicals increased access to proliferating gastric epithelial cells.2 21 Gastric juice vitamin C may play a role in the prevention of gastric cancer through its ability to scavenge oxygen free radicals and nitrite, a precursor of N-nitrosocompounds.22 23 Vitamin C secretion is impaired in subjects with H pylori associated gastritis,2425 and eradication of the organism returns secretion to normal. 26 We found that cell proliferation returned to normal four weeks after triple therapy, irrespective of the subject's H pylorn status. This may have been a non-specific effect of treatment. Bismuth has anti-inflammatory effects27 and may remain in the gastric mucosa for weeks after the completion of treatment. Because of this unexpected finding, patients were followed up with endoscopy and biopsy for a period ranging from six to 18 months after treatment. None of the patients had any other anti-helicobacter treatment in the interim. Those in whom H pylori eradication had been successful continued to have a normal mucosal proliferation rate but in those in whom eradication had failed cell proliferation returned to its previously high level.
This is the first report of the long term effect of H pylori eradication on gastric mucosal cell kinetics. Given that increased cell proliferation enhances the likelihood of genetic damage it seems reasonable to suggest that eradication of H pylori may reduce the risk of gastric neoplasia.28
In conclusion, we have shown that gastric mucosal cell proliferation is increased in H pylori associated gastritis and returns to normal after eradication therapy. This may have implications for gastric carcinogenesis and its prevention. 
